ProfileGDS4718 / 205455_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 94% 81% 94% 92% 83% 86% 93% 92% 92% 94% 90% 92% 86% 88% 89% 88% 88% 91% 93% 95% 93% 91% 92% 94% 86% 91% 88% 93% 89% 93% 88% 95% 94% 89% 85% 92% 94% 91% 60% 90% 93% 90% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.9680294
GSM549102patient 115, normal, homogenized [OPG study]10.087894
GSM549104patient 119, normal, homogenized [OPG study]8.0839281
GSM549108patient 138, normal, homogenized [OPG study]10.013994
GSM549119patient 077, normal, homogenized [OPG study]9.6185392
GSM549133patient 032, cancer, homogenized [OPG study]8.3441183
GSM549139patient 042, cancer, homogenized [OPG study]8.6387886
GSM549099patient 107, normal, homogenized [OPG study]9.6266993
GSM549109patient 139, normal, homogenized [OPG study]9.656592
GSM549110patient 046, normal, homogenized [OPG study]9.614692
GSM549114patient 063, normal, homogenized [OPG study]10.064594
GSM549122patient 082, normal, homogenized [OPG study]9.3055290
GSM549134patient 033, cancer, homogenized [OPG study]9.4832692
GSM549136patient 036, cancer, homogenized [OPG study]8.7468986
GSM549140patient 044, cancer, homogenized [OPG study]8.9571388
GSM549111patient 047, normal, homogenized [OPG study]9.1003389
GSM549113patient 057, normal, homogenized [OPG study]9.0139688
GSM549132patient 031, cancer, homogenized [OPG study]8.8792688
GSM549137patient 038, cancer, homogenized [OPG study]9.2303291
GSM549142patient 047, cancer, homogenized [OPG study]9.2532693
GSM549100patient 110, normal, homogenized [OPG study]10.230995
GSM549107patient 135, normal, homogenized [OPG study]9.767393
GSM549115patient 068, normal, homogenized [OPG study]9.6295591
GSM549116patient 072, normal, homogenized [OPG study]9.5849292
GSM549120patient 078, normal, homogenized [OPG study]10.116894
GSM549131patient 030, cancer, homogenized [OPG study]8.7617386
GSM549118patient 074, normal, homogenized [OPG study]9.460591
GSM549129patient 027, cancer, homogenized [OPG study]8.8040488
GSM549123patient 088, normal, homogenized [OPG study]9.8174893
GSM549124patient 006, cancer, homogenized [OPG study]8.9356589
GSM549126patient 015, cancer, homogenized [OPG study]9.6889493
GSM549128patient 025, cancer, homogenized [OPG study]8.8579988
GSM549103patient 117, normal, homogenized [OPG study]10.183595
GSM549117patient 073, normal, homogenized [OPG study]10.190494
GSM549138patient 041, cancer, homogenized [OPG study]9.0877589
GSM549141patient 045, cancer, homogenized [OPG study]8.5898185
GSM549130patient 028, cancer, homogenized [OPG study]9.4749292
GSM549101patient 111, normal, homogenized [OPG study]9.8307194
GSM549105patient 128, normal, homogenized [OPG study]9.3879891
GSM549106patient 134, normal, homogenized [OPG study]6.0830260
GSM549112patient 048, normal, homogenized [OPG study]9.1941990
GSM549125patient 011, cancer, homogenized [OPG study]9.694193
GSM549127patient 024, cancer, homogenized [OPG study]9.073890
GSM549135patient 035, cancer, homogenized [OPG study]8.0904581